Financial News

Financial Report: AbbVie

HUMIRA drives growth in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

AbbVie 1Q Revenues: $6.0 billion (+18%) 1Q Earnings: $1.3 billion (+32%) Comments: HUMIRA sales were $3.6 billion, up 15%. IMBRUVICA revenue was $381 million, with U.S. sales of $325 million and international profit sharing of $56 million for the quarter. Viekira sales were $414 million, up 79%. Creon sales were up 18% to $150 million. Synagis sales were down 5% to $319 million. Synthroid sales were down 2% to $182 million....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters